Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other neoplasm 1Head & Neck 1

Conditions

Precancerous Conditions 55Multiple Myeloma 10Lymphoma 10Leukemia 10Neoplasms, Plasma Cell 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Myelodysplastic Syndromes 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, T-Cell, Cutaneous 8Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Burkitt Lymphoma 8Primary Myelofibrosis 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Large-Cell, Anaplastic 7Leukemia, Myeloid, Acute 7Keratosis, Actinic 7Immunoblastic Lymphadenopathy 7Waldenstrom Macroglobulinemia 6Thrombocythemia, Essential 6Sezary Syndrome 6Mycosis Fungoides 6

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Tobacco Smoking × Other neoplasm × Clear all
NCT03347838 2025-12-12

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

University of Colorado, Denver

Phase 2 Active not recruiting
19 enrolled 10 charts
Head & NeckOther neoplasm

Tobacco Smoking, Head and Neck Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡